TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
SAI Life Sciences Ltd. ( (IN:SAILIFE) ) has shared an update.
Sai Life Sciences Limited has announced the reappointment of Mr. Krishnamraju Kanumuri as Managing Director & CEO, effective September 1, 2025, for a five-year term. Under his leadership, the company has achieved significant growth, including a 25% revenue CAGR from 2022 to 2025, expanded its global presence, and strengthened partnerships with top pharmaceutical clients, positioning it as a key player in the CRO-CDMO industry.
More about SAI Life Sciences Ltd.
Sai Life Sciences Limited is a leading global Contract Research and Development Manufacturing Organization (CRO-CDMO) that serves pharmaceutical and biotech innovators. The company has transformed from a domestic service provider into a globally respected entity, with strategic expansions including R&D centers in Boston and Manchester, and a successful IPO in December 2024.
Average Trading Volume: 366,016
Technical Sentiment Signal: Strong Buy
Current Market Cap: 165.6B INR
See more data about SAILIFE stock on TipRanks’ Stock Analysis page.